Harris Williams Advises Knox Lane on its Strategic Investment in Fingerpaint
Harris Williams advised Knox Lane on its strategic investment in Fingerpaint, a health and wellness marketing agency. This partnership aims to leverage Fingerpaint's innovative marketing services for the pharmaceutical sector, which has shown growing investor interest. Knox Lane, a middle market investment firm, seeks to accelerate growth by providing extensive support across business operations. Fingerpaint, recognized for its rapid growth and impactful services, aims to enhance its capabilities through this investment.
- Knox Lane's investment signifies strong investor interest in the technology-enabled pharma marketing services sector.
- Fingerpaint has experienced consistent growth through innovative marketing solutions for pharmaceutical clients.
- The partnership is expected to enhance Fingerpaint's operational capabilities and market position.
- None.
Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Knox Lane, a leading middle market investment firm focused on the consumer and services sectors, on its strategic investment in Fingerpaint, a full-service health and wellness marketing agency with five offices across the U.S. The transaction was led by Paul Hepper of the Harris Williams Healthcare & Life Sciences (HCLS) Group and Dan Linsalata of the firm’s Technology Group.
“Fingerpaint’s innovative approach to providing marketing services to pharmaceutical, rare disease and gene therapy clients has driven the company’s growth over the past 12 years,” said Paul Hepper, a managing director at Harris Williams. “Knox Lane will be a fantastic partner to Fingerpaint as it embarks on its next chapter.”
Dan Linsalata, a director at Harris Williams, added, “Knox Lane’s investment in Fingerpaint comes amidst deep investor interest in the technology-enabled pharma marketing services sector. This fragmented end market is benefitting from numerous positive tailwinds and firms with innovative offerings and strong backing will be well positioned for success.”
Formed in 2019 and based in San Francisco, Knox Lane is a middle market investment firm led by and comprised of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions and business development.
Independent by design, with integrated talent across five offices in New York, Pennsylvania, Arizona, New Jersey and California, Fingerpaint is built on a foundation of empathy and at its core is committed to creating and executing meaningful brand experiences for healthcare providers, care partners and patients. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located in La Jolla, California, adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine's list of the 5,000 Fastest-Growing Companies for the past seven years.
Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).
The Harris Williams HCLS Group has experience across a broad range of sectors, including healthcare providers; payors and payor services; outsourced pharmaceutical services; medical device supply chain; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.
The Harris Williams Technology Group advises leading private and public companies, entrepreneurs, private equity firms and venture capital firms on mergers and acquisitions and capital-raising transactions worldwide. The Technology Group has deep domain expertise in the IT Services, Software/SaaS and Internet & Digital Media segments, with particular emphasis on specific verticals including education technology, data analytics, energy technology, fintech, public sector, and supply chain/logistics—with a dedicated healthcare technology (HCIT) practice. Across verticals, the firm also advises technology services and networking solutions businesses. For more information on the Technology Group and its recent transactions, visit the Technology Group’s section of the Harris Williams website.
Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005597/en/
FAQ
What was the strategic investment announced by Knox Lane?
Who advised Knox Lane on its investment in Fingerpaint?
What sectors does Fingerpaint focus on?
What is Knox Lane's investment approach?
Why is the investment in Fingerpaint significant?
